G&E Healthcare Co., Ltd. (XKON:299480)

G&E Healthcare Statistics

Total Valuation

G&E Healthcare has a market cap or net worth of KRW 10.52 billion.

Market Cap	10.52B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

G&E Healthcare has 11.10 million shares outstanding.

Current Share Class	11.10M
Shares Outstanding	11.10M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 5.18.

PE Ratio	5.18
Forward PE	n/a
PS Ratio	1.36
PB Ratio	2.74
P/TBV Ratio	2.79
P/FCF Ratio	3.52
P/OCF Ratio	3.06
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.34.

Current Ratio	1.93
Quick Ratio	1.84
Debt / Equity	0.34
Debt / EBITDA	0.61
Debt / FCF	0.43
Interest Coverage	48.22

Financial Efficiency

Return on equity (ROE) is 61.03% and return on invested capital (ROIC) is 31.24%.

Return on Equity (ROE)	61.03%
Return on Assets (ROA)	22.58%
Return on Invested Capital (ROIC)	31.24%
Return on Capital Employed (ROCE)	39.75%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.40
Inventory Turnover	15.65

Taxes

In the past 12 months, G&E Healthcare has paid 372.54 million in taxes.

Income Tax	372.54M
Effective Tax Rate	18.93%

Stock Price Statistics

The stock price has increased by +140.70% in the last 52 weeks. The beta is -0.56, so G&E Healthcare's price volatility has been lower than the market average.

Beta (5Y)	-0.56
52-Week Price Change	+140.70%
50-Day Moving Average	484.60
200-Day Moving Average	508.84
Relative Strength Index (RSI)	76.35
Average Volume (20 Days)	146

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, G&E Healthcare had revenue of KRW 7.75 billion and earned 1.60 billion in profits. Earnings per share was 183.00.

Revenue	7.75B
Gross Profit	4.00B
Operating Income	2.01B
Pretax Income	1.97B
Net Income	1.60B
EBITDA	2.13B
EBIT	2.01B
Earnings Per Share (EPS)	183.00

Balance Sheet

The company has 4.58 billion in cash and 1.30 billion in debt, giving a net cash position of 3.28 billion or 295.19 per share.

Cash & Cash Equivalents	4.58B
Total Debt	1.30B
Net Cash	3.28B
Net Cash Per Share	295.19
Equity (Book Value)	3.85B
Book Value Per Share	441.27
Working Capital	2.70B

Cash Flow

In the last 12 months, operating cash flow was 3.44 billion and capital expenditures -445.87 million, giving a free cash flow of 2.99 billion.

Operating Cash Flow	3.44B
Capital Expenditures	-445.87M
Free Cash Flow	2.99B
FCF Per Share	269.29

Margins

Gross margin is 51.60%, with operating and profit margins of 25.89% and 20.59%.

Gross Margin	51.60%
Operating Margin	25.89%
Pretax Margin	25.40%
Profit Margin	20.59%
EBITDA Margin	27.53%
EBIT Margin	25.89%
FCF Margin	38.58%

Dividends & Yields

G&E Healthcare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	15.16%
FCF Yield	28.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

G&E Healthcare has an Altman Z-Score of 2.72 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.72
Piotroski F-Score	4